nodes	percent_of_prediction	percent_of_DWPC	metapath
Triprolidine—CYP2D6—Gefitinib—lung cancer	0.307	0.32	CbGbCtD
Triprolidine—CYP2D6—Vinorelbine—lung cancer	0.237	0.246	CbGbCtD
Triprolidine—CYP2D6—Erlotinib—lung cancer	0.182	0.189	CbGbCtD
Triprolidine—CYP2D6—Vinblastine—lung cancer	0.146	0.152	CbGbCtD
Triprolidine—CYP2D6—Doxorubicin—lung cancer	0.0897	0.0932	CbGbCtD
Triprolidine—HRH1—G alpha (q) signalling events—GNG11—lung cancer	0.00025	0.00656	CbGpPWpGaD
Triprolidine—HRH1—IL-4 Signaling Pathway—PIK3CD—lung cancer	0.00024	0.0063	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—lung cancer	0.000239	0.00627	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—lung cancer	0.000239	0.00627	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—CYP2A7—lung cancer	0.000231	0.00607	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—CYP2A7—lung cancer	0.000228	0.00598	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG11—lung cancer	0.000223	0.00587	CbGpPWpGaD
Triprolidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000215	0.00564	CbGpPWpGaD
Triprolidine—HRH1—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	0.000206	0.00542	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTA3—lung cancer	0.000206	0.00541	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—GSTA3—lung cancer	0.000203	0.00533	CbGpPWpGaD
Triprolidine—HRH1—G alpha (q) signalling events—ANXA1—lung cancer	0.000196	0.00516	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—GIPR—lung cancer	0.000192	0.00505	CbGpPWpGaD
Triprolidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.00019	0.005	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTA4—lung cancer	0.000188	0.00495	CbGpPWpGaD
Triprolidine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000188	0.00493	CbGpPWpGaD
Triprolidine—HRH1—G alpha (q) signalling events—APP—lung cancer	0.000186	0.00489	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—GSTA4—lung cancer	0.000186	0.00488	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTA2—lung cancer	0.000183	0.00482	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTA1—lung cancer	0.000177	0.00465	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	0.000177	0.00464	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	0.000177	0.00464	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—lung cancer	0.000176	0.00461	CbGpPWpGaD
Triprolidine—HRH1—IL-4 Signaling Pathway—EP300—lung cancer	0.000172	0.00453	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—AKR1C1—lung cancer	0.000167	0.00439	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—lung cancer	0.000166	0.00437	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—UGT1A1—lung cancer	0.000164	0.00432	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—GRM8—lung cancer	0.000163	0.00429	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—UGT1A1—lung cancer	0.000162	0.00426	CbGpPWpGaD
Triprolidine—HRH1—IL-4 Signaling Pathway—STAT3—lung cancer	0.000162	0.00425	CbGpPWpGaD
Triprolidine—HRH1—IL-4 Signaling Pathway—MAPK3—lung cancer	0.000154	0.00406	CbGpPWpGaD
Triprolidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000154	0.00405	CbGpPWpGaD
Triprolidine—HRH1—G alpha (q) signalling events—AVP—lung cancer	0.000145	0.0038	CbGpPWpGaD
Triprolidine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000142	0.00373	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—HPGDS—lung cancer	0.00014	0.00368	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTT1—lung cancer	0.000136	0.00356	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—OXTR—lung cancer	0.000135	0.00354	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—GRP—lung cancer	0.000135	0.00354	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GCLC—lung cancer	0.000134	0.00352	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—CYP2A6—lung cancer	0.000134	0.00352	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.00013	0.00342	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.000129	0.0034	CbGpPWpGaD
Triprolidine—HRH1—IL-4 Signaling Pathway—PIK3CA—lung cancer	0.000127	0.00335	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—GNG11—lung cancer	0.000126	0.00331	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000123	0.00324	CbGpPWpGaD
Triprolidine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000115	0.00302	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—CYP2E1—lung cancer	0.000114	0.003	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	0.000112	0.00296	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—GIPR—lung cancer	0.000109	0.00285	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—PTHLH—lung cancer	0.000105	0.00277	CbGpPWpGaD
Triprolidine—HRH1—IL-4 Signaling Pathway—AKT1—lung cancer	0.000104	0.00274	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—ANXA1—lung cancer	9.9e-05	0.0026	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—GIPR—lung cancer	9.86e-05	0.00259	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	9.58e-05	0.00252	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTP1—lung cancer	9.4e-05	0.00247	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—APP—lung cancer	9.38e-05	0.00247	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	9.27e-05	0.00244	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—GRM8—lung cancer	9.23e-05	0.00243	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—GSTM1—lung cancer	8.64e-05	0.00227	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	8.52e-05	0.00224	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	8.39e-05	0.0022	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—GRM8—lung cancer	8.38e-05	0.0022	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	8.19e-05	0.00215	CbGpPWpGaD
Triprolidine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	8.08e-05	0.00212	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	7.99e-05	0.0021	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—AXL—lung cancer	7.68e-05	0.00202	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—OXTR—lung cancer	7.6e-05	0.002	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—GRP—lung cancer	7.6e-05	0.002	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—AVP—lung cancer	7.3e-05	0.00192	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—AZIN2—lung cancer	7.2e-05	0.00189	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—COL4A3BP—lung cancer	7.2e-05	0.00189	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—GNG11—lung cancer	7.12e-05	0.00187	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	7.09e-05	0.00186	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—OXTR—lung cancer	6.9e-05	0.00181	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—GRP—lung cancer	6.9e-05	0.00181	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—GNG11—lung cancer	6.46e-05	0.0017	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—ADCY1—lung cancer	6.4e-05	0.00168	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	6.37e-05	0.00167	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ATP5H—lung cancer	6.13e-05	0.00161	CbGpPWpGaD
Triprolidine—CYP2D6—Biological oxidations—POMC—lung cancer	6.11e-05	0.0016	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—COL4A2—lung cancer	5.98e-05	0.00157	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—PTHLH—lung cancer	5.95e-05	0.00156	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—GIPR—lung cancer	5.82e-05	0.00153	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—ADCY1—lung cancer	5.81e-05	0.00153	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—PPP2R1B—lung cancer	5.66e-05	0.00149	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—ANXA1—lung cancer	5.59e-05	0.00147	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PLBD1—lung cancer	5.46e-05	0.00143	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—SDC4—lung cancer	5.44e-05	0.00143	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—PTHLH—lung cancer	5.4e-05	0.00142	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	5.34e-05	0.0014	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—DUSP3—lung cancer	5.33e-05	0.0014	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—APP—lung cancer	5.3e-05	0.00139	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—RHEB—lung cancer	5.22e-05	0.00137	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	5.11e-05	0.00134	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—ANXA1—lung cancer	5.08e-05	0.00133	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—HSD17B10—lung cancer	4.99e-05	0.00131	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—GRM8—lung cancer	4.95e-05	0.0013	CbGpPWpGaD
Triprolidine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	4.93e-05	0.00129	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	4.86e-05	0.00128	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—POMC—lung cancer	4.85e-05	0.00127	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—APP—lung cancer	4.81e-05	0.00127	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—SKI—lung cancer	4.8e-05	0.00126	CbGpPWpGaD
Triprolidine—HRH1—G alpha (q) signalling events—PIK3CA—lung cancer	4.72e-05	0.00124	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CKB—lung cancer	4.64e-05	0.00122	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	4.59e-05	0.00121	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTM2—lung cancer	4.36e-05	0.00115	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CNDP2—lung cancer	4.36e-05	0.00115	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—MTMR3—lung cancer	4.25e-05	0.00112	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	4.22e-05	0.00111	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PXN—lung cancer	4.16e-05	0.00109	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PGAM1—lung cancer	4.14e-05	0.00109	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—AVP—lung cancer	4.12e-05	0.00108	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—GRP—lung cancer	4.08e-05	0.00107	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—AKR1C1—lung cancer	4.08e-05	0.00107	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—OXTR—lung cancer	4.08e-05	0.00107	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CYP2A7—lung cancer	3.95e-05	0.00104	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	3.9e-05	0.00103	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—SDC4—lung cancer	3.86e-05	0.00102	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—GNG11—lung cancer	3.82e-05	0.001	CbGpPWpGaD
Triprolidine—HRH1—GPCR ligand binding—CXCL8—lung cancer	3.75e-05	0.000986	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—AVP—lung cancer	3.74e-05	0.000984	CbGpPWpGaD
Triprolidine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	3.74e-05	0.000982	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—VEGFC—lung cancer	3.63e-05	0.000955	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—RRM1—lung cancer	3.52e-05	0.000925	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTA3—lung cancer	3.52e-05	0.000925	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—ADCY1—lung cancer	3.43e-05	0.000902	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	3.34e-05	0.000879	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—SMARCA4—lung cancer	3.34e-05	0.000879	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—B4GALT5—lung cancer	3.31e-05	0.000869	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—HSPB1—lung cancer	3.23e-05	0.000848	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTA4—lung cancer	3.22e-05	0.000846	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PTHLH—lung cancer	3.19e-05	0.000839	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTA2—lung cancer	3.14e-05	0.000824	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTA1—lung cancer	3.03e-05	0.000795	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—ANXA1—lung cancer	3e-05	0.000788	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ABCC3—lung cancer	2.99e-05	0.000786	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—FLT1—lung cancer	2.91e-05	0.000764	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—AKR1C1—lung cancer	2.9e-05	0.000761	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	2.88e-05	0.000756	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—APP—lung cancer	2.84e-05	0.000747	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—NOTCH3—lung cancer	2.84e-05	0.000747	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—FGF9—lung cancer	2.82e-05	0.000741	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—UGT1A1—lung cancer	2.81e-05	0.000739	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—POMC—lung cancer	2.74e-05	0.00072	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GNG11—lung cancer	2.71e-05	0.000713	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—JUNB—lung cancer	2.69e-05	0.000708	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	2.61e-05	0.000687	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ALDOA—lung cancer	2.58e-05	0.000679	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	2.53e-05	0.000665	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—NCOA3—lung cancer	2.51e-05	0.000659	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—POMC—lung cancer	2.49e-05	0.000654	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—STK11—lung cancer	2.45e-05	0.000643	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ADCY1—lung cancer	2.44e-05	0.000641	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ABCG2—lung cancer	2.44e-05	0.000641	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—IL6R—lung cancer	2.43e-05	0.000638	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ENO2—lung cancer	2.39e-05	0.000629	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—HPGDS—lung cancer	2.39e-05	0.000629	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.38e-05	0.000625	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—FOXO3—lung cancer	2.36e-05	0.00062	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTT1—lung cancer	2.32e-05	0.00061	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	2.31e-05	0.000608	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	2.3e-05	0.000604	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GCLC—lung cancer	2.29e-05	0.000603	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CYP2A6—lung cancer	2.29e-05	0.000603	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—AVP—lung cancer	2.21e-05	0.000581	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	2.21e-05	0.00058	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ENO1—lung cancer	2.17e-05	0.000571	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—IGF1R—lung cancer	2.13e-05	0.00056	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	2.12e-05	0.000557	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—HES1—lung cancer	2.09e-05	0.00055	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—RAF1—lung cancer	2.05e-05	0.000539	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—IL2—lung cancer	2.03e-05	0.000532	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	2e-05	0.000526	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.95e-05	0.000512	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—NQO1—lung cancer	1.93e-05	0.000507	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—CXCL8—lung cancer	1.92e-05	0.000506	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—ERBB3—lung cancer	1.91e-05	0.000503	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—IL2—lung cancer	1.84e-05	0.000483	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—TERT—lung cancer	1.83e-05	0.000482	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—FGFR1—lung cancer	1.78e-05	0.000468	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—HIF1A—lung cancer	1.75e-05	0.000461	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—STK11—lung cancer	1.74e-05	0.000457	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—APOA1—lung cancer	1.69e-05	0.000445	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—KDR—lung cancer	1.68e-05	0.000441	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTP1—lung cancer	1.61e-05	0.000423	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CAT—lung cancer	1.56e-05	0.000411	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—APC—lung cancer	1.54e-05	0.000406	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PIK3CG—lung cancer	1.54e-05	0.000406	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—KIT—lung cancer	1.54e-05	0.000406	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—NRAS—lung cancer	1.54e-05	0.000406	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—EGF—lung cancer	1.53e-05	0.000401	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ABCB1—lung cancer	1.52e-05	0.0004	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—TYMS—lung cancer	1.49e-05	0.000393	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—MAPK3—lung cancer	1.48e-05	0.000389	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—GSTM1—lung cancer	1.48e-05	0.000388	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—POMC—lung cancer	1.47e-05	0.000386	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—BRAF—lung cancer	1.45e-05	0.000381	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—IL6R—lung cancer	1.43e-05	0.000377	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—CREBBP—lung cancer	1.43e-05	0.000376	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—EGFR—lung cancer	1.41e-05	0.00037	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.4e-05	0.000368	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ERCC2—lung cancer	1.39e-05	0.000365	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—MAP2K1—lung cancer	1.37e-05	0.000359	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PIK3CD—lung cancer	1.36e-05	0.000357	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	1.34e-05	0.000353	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—KRAS—lung cancer	1.33e-05	0.000349	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	1.22e-05	0.000321	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—MDM2—lung cancer	1.22e-05	0.00032	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—RAF1—lung cancer	1.21e-05	0.000318	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—APOA1—lung cancer	1.2e-05	0.000316	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—ERBB2—lung cancer	1.2e-05	0.000315	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—MTOR—lung cancer	1.18e-05	0.000311	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.18e-05	0.000311	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—CXCL8—lung cancer	1.14e-05	0.000299	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—HRAS—lung cancer	1.13e-05	0.000297	CbGpPWpGaD
Triprolidine—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.1e-05	0.000289	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.1e-05	0.000288	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—CASP3—lung cancer	1.09e-05	0.000286	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—IL2—lung cancer	1.09e-05	0.000286	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—IL6—lung cancer	1.08e-05	0.000284	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—CCND1—lung cancer	1.06e-05	0.000278	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—JUN—lung cancer	1.06e-05	0.000278	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—POMC—lung cancer	1.04e-05	0.000274	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—MMP9—lung cancer	1.03e-05	0.00027	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.02e-05	0.000269	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PTEN—lung cancer	1.02e-05	0.000269	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—CREBBP—lung cancer	1.02e-05	0.000267	CbGpPWpGaD
Triprolidine—HRH1—Signaling by GPCR—AKT1—lung cancer	9.97e-06	0.000262	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—EP300—lung cancer	9.75e-06	0.000256	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PIK3CD—lung cancer	9.64e-06	0.000253	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—ALB—lung cancer	9.52e-06	0.00025	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—SRC—lung cancer	9.48e-06	0.000249	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—VEGFA—lung cancer	9.23e-06	0.000243	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—STAT3—lung cancer	9.14e-06	0.00024	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—NRAS—lung cancer	9.12e-06	0.00024	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—MAPK3—lung cancer	8.74e-06	0.00023	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—MYC—lung cancer	8.5e-06	0.000223	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PIK3CB—lung cancer	8.41e-06	0.000221	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PTGS2—lung cancer	8.33e-06	0.000219	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—EGFR—lung cancer	8.31e-06	0.000218	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—KRAS—lung cancer	7.85e-06	0.000206	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PTEN—lung cancer	7.26e-06	0.000191	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—PIK3CA—lung cancer	7.21e-06	0.00019	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—TP53—lung cancer	6.98e-06	0.000183	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—EP300—lung cancer	6.93e-06	0.000182	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—HRAS—lung cancer	6.67e-06	0.000175	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—IL6—lung cancer	6.39e-06	0.000168	CbGpPWpGaD
Triprolidine—HRH1—Signaling Pathways—AKT1—lung cancer	5.89e-06	0.000155	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—PIK3CA—lung cancer	5.12e-06	0.000135	CbGpPWpGaD
Triprolidine—CYP2D6—Metabolism—AKT1—lung cancer	4.19e-06	0.00011	CbGpPWpGaD
